Picard Medical (PMI) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$6.3M

Revenue (quarter)

$3.0M

Revenue growth (year over year)

+38.62%

Gross profit (trailing twelve months)

$1.2M

Gross margin

18.60%

Net income (trailing twelve months)

−$28.0M

Net income (quarter)

−$5.7M

Net income growth (year over year)

+15.82%

Net margin

−444.33%

Return on equity

—

EPS (trailing twelve months)

$36.89

Book value per share

$0.84

P/E (trailing twelve months)

—

Price to book

15.45

Debt to assets

81.28%

Payout ratio

—

Dividend yield

—

Company profile

Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.

• Is Picard Medical (PMI) profitable?

  No. Picard Medical reported a net loss of $28.0M over the trailing twelve months.

• How much revenue does Picard Medical (PMI) make?

  Picard Medical generated $6.3M in revenue over the trailing twelve months, up 38.62% year over year.

• How do I buy stock in Picard Medical (PMI)?

  PMI trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.